The standout three‑month outperformance (+36.7% vs +27.2%) signals that recent operational improvements—particularly higher gross margins on cleaning solutions—are translating into tangible shareholder upside, making TNC a compelling short‑term play relative to the broader market.
A key risk is the concentration of revenue in North American industrial cleaning, which accounts for roughly 70% of sales; a prolonged slowdown in U.S. manufacturing could depress earnings growth by up to 3% annually, eroding the modest long‑term outperformance and pressuring the stock's valuation multiples.
A potential divergence looms as insiders have a net purchase‑sale ratio of only 5.67%; while positive, it is relatively small compared to the 4.92% institutional inflow, suggesting that management may be less aggressive than external investors, which could signal limited upside confidence if earnings guidance softens.
The 3.3% three‑year revenue CAGR is a key positive, because it demonstrates that Tennant’s strategic pivot to higher‑value, technology‑driven offerings is beginning to reverse the prior decline and sets a foundation for sustainable growth beyond short‑term cyclicality.
Operating margin compression poses a risk: at 5.7%, an additional 1‑point increase in SG&A or depreciation would cut net income by roughly $12 m (≈4% of revenue), potentially triggering covenant breaches and reducing cash generation capacity.
The 49% plunge in asset turnover is the most consequential driver, implying that TNC’s recent capital deployments are not translating into proportional sales growth, a red flag for sustainable return generation.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 7.3 | 3.6 | 0.95 | 2.11 | 8.4 | 7.0 | 3.5 |
| 2024 | 13.5 | 6.5 | 1.08 | 1.92 | 21.6 | 12.7 | 7.0 |
| 2023 | 19.0 | 8.8 | 1.12 | 1.93 | 17.9 | 16.5 | 9.8 |
| 2022 | 14.1 | 6.1 | 1.01 | 2.30 | 11.1 | 10.6 | 6.1 |
| 2021 | 15.0 | 5.9 | 1.03 | 2.45 | 12.6 | 12.1 | 6.1 |
| 2020 | 8.3 | 3.4 | 0.92 | 2.67 | 7.9 | 7.7 | 3.1 |
| 2019 | 12.7 | 4.0 | 1.07 | 2.95 | 9.5 | 9.1 | 4.3 |
| 2018 | 10.6 | 3.0 | 1.13 | 3.16 | 8.1 | 7.8 | 3.4 |
| 2017 | -2.1 | -0.6 | 1.01 | 3.35 | 3.7 | 3.6 | -0.6 |
| 2016 | 16.7 | 5.8 | 1.72 | 1.69 | 22.5 | 20.3 | 9.9 |
| 2015 | 12.7 | 4.0 | 1.88 | 1.71 | 19.3 | 17.8 | 7.4 |
The 114‑day cash conversion cycle represents a $45 million increase in operating working capital year‑over‑year, which could pressure liquidity if sales growth stalls or credit terms tighten.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 385 | 101 | 78 | 75 | 65 | 114 |
| 2024 | 338 | 91 | 73 | 63 | 102 | |
| 2023 | 327 | 90 | 73 | 67 | 57 | 106 |
| 2022 | 363 | 112 | 84 | 71 | 69 | 128 |
| 2021 | 355 | 90 | 71 | 72 | 68 | 93 |
| 2020 | 395 | 79 | 73 | 84 | 65 | 86 |
| 2019 | 341 | 81 | 72 | 71 | 51 | 102 |
| 2018 | 322 | 73 | 68 | 53 | 53 | 87 |
| 2017 | 362 | 78 | 76 | 66 | 59 | 96 |
| 2016 | 212 | 63 | 67 | 51 | 38 | 92 |
| 2015 | 194 | 61 | 63 | 43 | 40 | 84 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1269M | $666M | $602M | $345M | $238M | $106M | $600M | $293M |
| 2024 | $1190M | $568M | $621M | $254M | $155M | $100M | $577M | $292M |
| 2023 | $1113M | $535M | $577M | $242M | $126M | $117M | $569M | $274M |
| 2022 | $1085M | $613M | $471M | $332M | $255M | $77M | $575M | $262M |
| 2021 | $1062M | $627M | $434M | $309M | $186M | $123M | $527M | $290M |
| 2020 | $1083M | $676M | $405M | $354M | $213M | $140M | $494M | $254M |
| 2019 | $1063M | $702M | $360M | $386M | $312M | $74M | $481M | $275M |
| 2018 | $993M | $676M | $314M | $355M | $269M | $86M | $469M | $249M |
| 2017 | $994M | $696M | $297M | $377M | $318M | $58M | $423M | $237M |
| 2016 | $470M | $191M | $279M | $36M | $-22M | $58M | $298M | $133M |
| 2015 | $432M | $180M | $252M | $25M | $-27M | $51M | $294M | $133M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $65M | $-23M | $-39M | $-22M | $43M | $-88M | $-22M |
| 2024 | $90M | $-78M | $-25M | $-21M | $68M | $-20M | $-21M |
| 2023 | $188M | $-23M | $-123M | $-24M | $164M | $-22M | $-20M |
| 2022 | $-25M | $-24M | $8M | $-29M | $-54M | $-5M | $-19M |
| 2021 | $69M | $2M | $-84M | $-23M | $46M | $-15M | $-18M |
| 2020 | $134M | $-30M | $-43M | $-30M | $104M | $-16M | |
| 2019 | $72M | $-56M | $-27M | $-39M | $33M | $-16M | |
| 2018 | $80M | $-16M | $-33M | $-22M | $58M | $-15M | |
| 2017 | $54M | $-375M | $319M | $-23M | $31M | $-15M | |
| 2016 | $58M | $-40M | $-10M | $-27M | $31M | $-13M | $-14M |
| 2015 | $45M | $-24M | $-61M | $-25M | $20M | $-46M | $-14M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net